Font Size: a A A
Keyword [Conversion therapy]
Result: 21 - 29 | Page: 2 of 2
21. Value Of Neoadjuvant/conversion Therapy In Borderline Resectable(BR)/Locally Advanced(LA) Pancreatic Cancer
22. The Application Of Immune Checkpoint Inhibitors In Unresectable Hepatocellular Carcinoma:Clinical Exploration And A Meta-Analysis Of Prognosis
23. Efficacy And Safety Of Donafenib Combined With Anti-PD-1 Antibodies Plus Transarterial Therapy For Unresectable Hepatocellular Carcinoma
24. Efficacy And Safety Analysis Of Interventional Therapy Combined With Targeted Therapy And Immunotherapy Compared With Interventional Therapy Alone In Unresectable Hepatocellular Carcinoma
25. Establishment And Validation Of A Prognostic Stratification Model Based On Clinical Prognostic Factors For Pancreatic Cancer After Neoadjuvant/Conversion Therapy
26. A Comparison Of The Efficacy Of Donafenib Versus Lenvatinib (Combined Interventional Therapy) In Conversion Therapy For HCC Patients
27. A Retrospective Study Of Single-center Conversion Therapy For Advanced Hepatocellular Carcinoma
28. To Observe The Safety And Clinical Efficacy Of Immunotherapy Combined With Targeted Therapy In The Conversion Therapy Of Advanced Liver Cancer
29. SITS Combination Therapy In Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
  <<First  <Prev  Next>  Last>>  Jump to